The Role of Immune System Dysfunction in Co-Existence of Neurological Disorders in Psoriasis

  • Man Amanat NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. AND Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Mona Salehi NeuroImmunology Research Association (NIRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran. AND Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Nima Rezaei Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Immunology and Biology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.AND Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
Keywords: No keywords###

Abstract

No Abstract###

References

Amanat M, Salehi M, Rezaei N. Neurological and psychiatric disorders in psoriasis. Rev Neurosci. 2018. [Ehead of print]

Baliwag J, Barnes DH, Johnston A. Cytokines in psoriasis. Cytokine. 2015;73:342-50.

Grine L, Dejager L, Libert C, Vandenbroucke RE. An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine Growth Factor Rev. 2015;26:25-33.

Michalak-Stoma A, Bartosińska J, Kowal M, Juszkiewicz-Borowiec M, Gerkowicz A, Chodorowska G. Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. Dis markers. 2013;35:625-31.

Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, Vivien D. Stroke and the immune system: from pathophysiology to new therapeutic strategies. The Lancet Neurology. 2011;10:471-80.

Luchtman DW, Ellwardt E, Larochelle C, Zipp F. IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: current and future developments. Cytokine Growth Factor Rev. 2014;25:403-13.

Iori V, Frigerio F, Vezzani A. Modulation of neuronal excitability by immune mediators in epilepsy. Curr Opin Pharmacol. 2016;26:118-23.

Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7:31-40.

de Vries EE, van den Munckhof B, Braun KP, van Royen-Kerkhof A, de Jager W, Jansen FE. Inflammatory mediators in human epilepsy: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2016;63:177-90.

Vezzani A. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?. Expert Opin Drug Safe. 2015;14:583-92.

Rannikko EH, Weber SS, Kahle PJ. Exogenous α-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci. 2015;16:57.

Deleidi M, Gasser T. The role of inflammation in sporadic and familial Parkinson’s disease. Cell Mol Life Sci. 2013;70:4259-73.

Rahmani F, Rezaei N. Therapeutic targeting of toll-like receptors: a review of toll-like receptors and their signaling pathways in psoriasis. Expert Rev Clin Immunol. 2016;12:1289-98.

Capo A, Affaitati G, Giamberardino MA, Amerio P. Psoriasis and migraine. J Eur Acad Dermatol Venereol. 2018;32:57-61.

Amanat M, Salehi M, Rezaei N. A Guideline for Early Diagnosis of Autoimmune Epilepsy Based on Clinical Manifestations and Common Para-clinical Tests. Acta Med Iran. 2018;56:419-20.

Published
2018-12-25
How to Cite
1.
Amanat M, Salehi M, Rezaei N. The Role of Immune System Dysfunction in Co-Existence of Neurological Disorders in Psoriasis. Acta Med Iran. 56(9):620-2.
Section
Letter to the Editor